The chemical class known as RFPL1 activators encompasses a range of compounds that influence the ubiquitin-proteasome system, with the intent of modulating the activity of the E3 ubiquitin ligase RFPL1. These activators operate by engaging various mechanisms that result in an upregulation of E3 ligase function, which is central to protein turnover and cellular homeostasis. By inhibiting proteasome function or interfering with ubiquitin-related enzymes, these chemicals can cause an accumulation of ubiquitinated proteins within the cell. This buildup often triggers a compensatory cellular response that seeks to restore equilibrium by enhancing the expression and activity of E3 ligases. RFPL1, being part of the E3 ligase family, can be activated in such a scenario, leading to an increase in its ubiquitination activity.
The action of these activators is not limited to the direct inhibition of the proteasome. Some members of this class also target upstream elements of the ubiquitination cascade, such as E1 activating enzymes or deubiquitinating enzymes. By modulating these enzymes, the activators can indirectly influence the ubiquitination process. For instance, an inhibitor of the E1 activating enzyme can increase the cellular demand for ubiquitin ligase activity to maintain protein homeostasis. Similarly, blocking deubiquitinating enzymes can elevate ubiquitinated protein levels, thus potentially increasing the ubiquitin ligase activity of RFPL1. These chemical activators are essential for understanding the dynamics of the ubiquitination system and the role of RFPL1 within it. Through careful manipulation of ubiquitin-related processes, these compounds offer insights into the complex regulatory mechanisms that govern protein life cycles in cellular environments.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can increase the levels of ubiquitinated proteins, potentially increasing the demand for E3 ligase activity, which could possibly activate RFPL1 involved in ubiquitination. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
An irreversible inhibitor of the E1 ubiquitin-activating enzyme, which may lead to compensatory mechanisms that could possibly activate E3 ligases such as RFPL1 to maintain protein homeostasis. | ||||||
SMER28 | 307538-42-7 | sc-222320 | 10 mg | $173.00 | ||
A small molecule enhancer of rapamycin that induces autophagy, possibly increasing the need for ubiquitin E3 ligases in the autophagic process, which could possibly activate RFPL1. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor used to cause the buildup of ubiquitinated proteins, which may could possibly activate E3 ligases including RFPL1 to counteract proteotoxic stress. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
A specific inhibitor of the proteasome that can lead to increased ubiquitinated proteins, which could possibly activate the cellular role of E3 ligases such as RFPL1. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
A selective proteasome inhibitor that can lead to increased levels of ubiquitinated proteins, necessitating greater E3 ligase activity from proteins like RFPL1, which could possibly activate them. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
An inhibitor of NEDD8-activating enzyme, affecting cullin-RING ligases, which might result in a compensatory upregulation of other E3 ligases, possibly including RFPL1, which could possibly activate it. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
Also known as Leupeptin, it is a protease inhibitor that can increase the level of ubiquitinated proteins, potentially enhancing E3 ligase activities, including RFPL1, which could possibly activate it. | ||||||